Published in Br J Clin Pharmacol on January 01, 1978
Biochemical assessment of antidepressive drugs. Br J Clin Pharmacol (1980) 0.75
The effect of the serotonergic receptor antagonist mianserine on the activity of Na, K-ATPase from rat cerebral cortex membranes. Dokl Biol Sci (2002) 0.75
A simple and sensitive saturation assay method for the measurement of adenosine 3':5'-cyclic monophosphate. Biochem J (1971) 8.85
3',5' cyclic adenosine monophosphate in depression and mania. Lancet (1970) 1.78
Abnormality of the blood-cerebrospinal fluid barrier of patients suffering from a depressive illness. J Neurol Neurosurg Psychiatry (1960) 1.33
Placebo-controlled double-blind trial of mianserin hydrochloride. Br J Clin Pharmacol (1978) 1.21
Erythrocyte membrane cation carrier in depressive illness. Psychol Med (1973) 1.03
Cyclic A.M.P. in affective disorders. Lancet (1970) 0.87
Erythrocyte membrane cation carrier, relapse rate of manic-depressive illness and response to lithium. Psychol Med (1976) 0.87
Diminished membrane transport in manic-depressive psychosis and recurrent depression. Lancet (1968) 0.84
Arsenic ingestion and internal cancers: a review. Am J Epidemiol (1992) 4.39
Diesel exhaust exposure and lung cancer. Epidemiology (1998) 4.08
Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal, India. Int J Epidemiol (1998) 4.07
Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology (1996) 3.49
Lung and kidney cancer mortality associated with arsenic in drinking water in Córdoba, Argentina. Int J Epidemiol (1998) 2.92
Methylation study of a population environmentally exposed to arsenic in drinking water. Environ Health Perspect (1996) 2.83
Lung cancer and arsenic concentrations in drinking water in Chile. Epidemiology (2000) 2.67
B-lymphocyte heterogeneity: development and characterization of an alloantiserum which distinguishes B-lymphocyte differentiation alloantigens. J Exp Med (1977) 2.44
Case-control study of bladder cancer and arsenic in drinking water. Am J Epidemiol (1995) 2.19
Is an antihistamine-decongestant combination effective in temporarily relieving symptoms of the common cold in preschool children? J Pediatr (1997) 2.18
Human studies do not support the methylation threshold hypothesis for the toxicity of inorganic arsenic. Environ Res (1993) 2.03
Arsenic in drinking water and the prevalence of respiratory effects in West Bengal, India. Int J Epidemiol (2000) 2.03
Synergism between occupational arsenic exposure and smoking in the induction of lung cancer. Epidemiology (1992) 1.90
Uptake of ( 3 H)ouabain and Na pump turnover rates in cells cultured in ouabain. J Physiol (1972) 1.82
Meta-analysis of benzene exposure and non-Hodgkin lymphoma: biases could mask an important association. Occup Environ Med (2008) 1.82
Abnormal ratio of membrane immunoglobulin classes in mice with an X-linked B-lymphocyte defect. J Exp Med (1975) 1.82
Subversion of immune system by tumor cells and role of prostaglandins. Proc Natl Acad Sci U S A (1975) 1.76
Vascular effects of chronic arsenic exposure: a review. Epidemiol Rev (1994) 1.71
De-functioning stomas: a prospective controlled trial comparing loop ileostomy with loop transverse colostomy. Br J Surg (1986) 1.71
Consistent pattern of elevated symptoms in air-conditioned office buildings: a reanalysis of epidemiologic studies. Am J Public Health (1990) 1.66
A large 4 pi plastic scintillator-detector with clinical applications. Int J Appl Radiat Isot (1967) 1.62
Increased micronuclei in exfoliated bladder cells of individuals who chronically ingest arsenic-contaminated water in Nevada. Cancer Epidemiol Biomarkers Prev (1995) 1.60
Chronic low-level lead exposure. Its role in the pathogenesis of hypertension. Med Toxicol (1987) 1.54
Serum vitamin A (retinol) and cancer incidence in Evans County, Georgia. J Natl Cancer Inst (1981) 1.52
Arsenic in drinking water and mortality from vascular disease: an ecologic analysis in 30 counties in the United States. Arch Environ Health (1994) 1.52
Non-Hodgkin's lymphoma and farming: an expanded case-control study. Int J Cancer (1987) 1.51
Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors. Thorax (2000) 1.51
Arsenic methylation patterns before and after changing from high to lower concentrations of arsenic in drinking water. Environ Health Perspect (1996) 1.48
Non-Hodgkin's lymphoma and exposure to phenoxyherbicides, chlorophenols, fencing work, and meat works employment: a case-control study. Br J Ind Med (1986) 1.46
Delayed health hazards of pesticide exposure. Annu Rev Public Health (1986) 1.45
Pregnancy outcomes, infant mortality, and arsenic in drinking water in West Bengal, India. Am J Epidemiol (2006) 1.43
Skin content of 7-dehydrocholesterol in patients with malabsorption. Nutrition (1997) 1.42
Soft tissue sarcoma and exposure to phenoxyherbicides and chlorophenols in New Zealand. J Natl Cancer Inst (1984) 1.37
Mortality and social class in New Zealand. I: overall male mortality. N Z Med J (1983) 1.36
Malignant lymphoma and multiple myeloma linked with agricultural occupations in a New Zealand Cancer Registry-based study. Am J Epidemiol (1985) 1.34
Observations on the dose-response curve for arsenic exposure and lung cancer. Scand J Work Environ Health (1993) 1.34
Serum retinol and the inverse relationship between serum cholesterol and cancer. Br Med J (Clin Res Ed) (1982) 1.33
Arsenic in drinking water and bladder cancer. Cancer Invest (2000) 1.32
Relationship of urinary arsenic to intake estimates and a biomarker of effect, bladder cell micronuclei. Mutat Res (1997) 1.31
Influence of Salts in the Diet on the Intestinal Flora of the Albino Rat. J Bacteriol (1937) 1.31
An examination of the relationship between fluoridation of water and cancer mortality in 20 large US cities. N Z Med J (1980) 1.31
The relationship of serum cholesterol to the incidence of cancer in Evans County, Georgia. J Chronic Dis (1980) 1.31
Effect of growth in lithium on ouabain binding, Na-K-ATPase and Na and K transport in hela cells. J Physiol (1975) 1.22
Diet and bladder cancer: a meta-analysis of six dietary variables. Am J Epidemiol (2000) 1.21
Placebo-controlled double-blind trial of mianserin hydrochloride. Br J Clin Pharmacol (1978) 1.21
Plasma levels of imipramine and desmethylimipramine during therapy. Br J Psychiatry (1967) 1.21
Effect of calf serum on sodium pump density in HeLa cells. Nat New Biol (1973) 1.18
Case-control study of multiple myeloma and farming. Br J Cancer (1986) 1.18
Intraocular melanoma linked to occupations and chemical exposures. Epidemiology (1996) 1.17
Linkage of a gene causing familial focal segmental glomerulosclerosis to chromosome 11 and further evidence of genetic heterogeneity. Genomics (1999) 1.17
Why smoke fewer cigarettes? Br Med J (Clin Res Ed) (1982) 1.12
Long term changes in total body water, total exchangable sodium and total body potassium before and after ileostomy. Br J Surg (1975) 1.08
Lithium in non-manic-depressives: antiaggressive effect and red blood cell lithium values. Br J Psychiatry (1975) 1.08
Defective genetic control of sodium-pump density in manic depressive psychosis. Psychol Med (1981) 1.08
Micronuclei in exfoliated bladder cells among individuals chronically exposed to arsenic in drinking water. Cancer Epidemiol Biomarkers Prev (1997) 1.08
A standardized benchmark approach to the use of cancer epidemiology data for risk assessment. Toxicol Ind Health (1985) 1.07
Mortality and social class in New Zealand II: male mortality by major disease groupings. N Z Med J (1983) 1.07
Changes in the Structure of the Developing Tooth in Rats Maintained on a Diet Deficient in Vitamin A. Yale J Biol Med (1941) 1.07
Congenital defects and miscarriages among New Zealand 2, 4, 5-T sprayers. Arch Environ Health (1982) 1.07
Dental Changes in Rats Consuming a Diet Poor in Inorganic Salts. Yale J Biol Med (1936) 1.06
Cross-calibration of GE/Lunar pencil and fan-beam dual energy densitometers--bone mineral density and body composition studies. Eur J Clin Nutr (2003) 1.04
Use of unabsorbed radioactive marker substances in a re-assessment of the radioactive triolein test of fat absorption. J Clin Pathol (1971) 1.04
Social class, ethnic group, and male mortality in New Zealand, 1974-8. J Epidemiol Community Health (1985) 1.04
Determinants of differences in mortality between New Zealand Maoris and non-Maoris aged 15-64. N Z Med J (1984) 1.03
Elevated blood pressure in treated hypertensives with low-level lead accumulation. Arch Environ Health (1989) 1.03
Supershrimp: deep bioturbation in the strait of canso, nova scotia. Science (1976) 1.02
Influence of life events and family routines on childhood respiratory tract illness. Pediatrics (1977) 0.99
Clinical studies on whole-body potassium content measured by gamma-ray spectrometry in health and disease. Clin Sci (1967) 0.99
Measurement of organ blood flow with coloured microspheres in the rat. Cardiovasc Res (1995) 0.98
Decrease in bladder cell micronucleus prevalence after intervention to lower the concentration of arsenic in drinking water. Cancer Epidemiol Biomarkers Prev (1997) 0.98
Increased risks of soft tissue sarcoma, malignant lymphoma, and acute myeloid leukemia in abattoir workers. Am J Ind Med (1988) 0.98
Influence of race, tobacco use, and caffeine use on the relation between blood pressure and blood lead concentration. Am J Epidemiol (1990) 0.98
A controlled trial of methylene blue in severe depressive illness. Biol Psychiatry (1987) 0.97
Cholecystectomy and cancer of the large bowel. Br J Surg (1981) 0.97
A new method for the rapid measurement of body composition in critically ill surgical patients. Br J Surg (1978) 0.97
Ammonia absorption from the canine colon after portacaval shunt. Br J Surg (1977) 0.97
Use of the fluorescent micronucleus assay to detect the genotoxic effects of radiation and arsenic exposure in exfoliated human epithelial cells. Environ Mol Mutagen (1996) 0.97
A novel sodium-hydrogen exchanger isoform-1 inhibitor, zoniporide, reduces ischemic myocardial injury in vitro and in vivo. J Pharmacol Exp Ther (2001) 0.96
Comparative sensitivities to antimicrobial agents of Campylobacter pylori and the gastric campylobacter like organism from the ferret. J Clin Pathol (1987) 0.96
Major colorectal cancer aetiological hypotheses do not explain mortality trends among Maori and non-Maori New Zealanders. Int J Epidemiol (1985) 0.96
Tissue Changes Associated with Vitamin A Deficiency in the Rat. Am J Pathol (1929) 0.96
Effect of chronic hypoxia on the pulmonary arterial blood pressure of the chicken. Am J Physiol (1968) 0.95
Circadian rhythms of water and electrolyte excretion in manic-depressive psychosis. Br J Psychiatry (1969) 0.95
Multi-element analysis of the living body by neutron activation analysis-application to critically ill patients receiving intravenous nutrition. Br J Surg (1979) 0.94
Epidemiologic investigation of occupational carcinogenesis using a serially additive expected dose model. Am J Epidemiol (1980) 0.94
A case-control study of prostate cancer within a cohort of rubber and tire workers. J Occup Med (1980) 0.94
Circulating erythroid progenitors in the anemia of prematurity. N Engl J Med (1987) 0.93
Blood pressure and blood lead concentration in bus drivers. Environ Health Perspect (1988) 0.92
Hormone profiles and psychological symptoms in peri-menopausal women. Maturitas (1987) 0.92
Mortality and social class in New Zealand. III: male mortality by ethnic group. N Z Med J (1984) 0.91
Characterization of the immunosuppressive state during Schistosoma mansoni infection. J Immunol (1979) 0.90
Controlled studies of the acute antidepressant effects of lithium. Br J Psychiatry (1979) 0.90
Aldose reductase inhibition alone or combined with an adenosine A(3) agonist reduces ischemic myocardial injury. Am J Physiol Heart Circ Physiol (2000) 0.89
Studies on non-H-2 linked lymphocyte activating determinants. I. Description of the cell type bearing the Mls product. J Immunogenet (1977) 0.89
Erythrocyte membrane cation carrier in mania. Psychol Med (1976) 0.88
Relationship between blood pressure and modernity among Ponapeans. Int J Epidemiol (1983) 0.88
Tissue vanadium levels in manic-depressive psychosis. Psychol Med (1984) 0.87
Lithium and erythrocyte membrane cation carrier studies in normal and manic depressive subjects. Psychol Med (1977) 0.86